Truist Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $523M | Buy |
2,404,493
+2,223
| +0.1% | +$493K | 0.71% | 26 |
|
|
2025
Q4 | $549M | Buy |
2,402,270
+96,251
| +4% | +$21.9M | 0.73% | 22 |
|
|
2025
Q3 | $534M | Buy |
2,306,019
+124,756
| +6% | +$25.4M | 0.72% | 24 |
|
|
2025
Q2 | $405M | Buy |
2,181,263
+140,414
| +7% | +$26.1M | 0.59% | 31 |
|
|
2025
Q1 | $428M | Sell |
2,040,849
-26,505
| -1% | -$5.15M | 0.68% | 26 |
|
|
2024
Q4 | $367M | Sell |
2,067,354
-120,092
| -5% | -$22.1M | 0.57% | 31 |
|
|
2024
Q3 | $432M | Sell |
2,187,446
-689,014
| -24% | -$129M | 0.68% | 27 |
|
|
2024
Q2 | $493M | Sell |
2,876,460
-10,869
| -0.4% | -$1.8M | 0.75% | 20 |
|
|
2024
Q1 | $526M | Sell |
2,887,329
-66,186
| -2% | -$11.4M | 0.8% | 22 |
|
|
2023
Q4 | $458M | Sell |
2,953,515
-257,427
| -8% | -$37.5M | 0.73% | 25 |
|
|
2023
Q3 | $479M | Buy |
3,210,942
+62,836
| +2% | +$9.22M | 0.8% | 21 |
|
|
2023
Q2 | $424M | Sell |
3,148,106
-37,078
| -1% | -$5.44M | 0.71% | 27 |
|
|
2023
Q1 | $508M | Sell |
3,185,184
-49,822
| -2% | -$7.62M | 0.87% | 18 |
|
|
2022
Q4 | $523M | Sell |
3,235,006
-20,789
| -0.6% | -$3.19M | 0.92% | 14 |
|
|
2022
Q3 | $437M | Sell |
3,255,795
-10,431
| -0.3% | -$1.5M | 0.84% | 19 |
|
|
2022
Q2 | $500M | Sell |
3,266,226
-146,959
| -4% | -$22.5M | 0.92% | 13 |
|
|
2022
Q1 | $553M | Sell |
3,413,185
-113,736
| -3% | -$16.5M | 0.87% | 17 |
|
|
2021
Q4 | $478M | Sell |
3,526,921
-37,034
| -1% | -$4.37M | 0.73% | 18 |
|
|
2021
Q3 | $384M | Buy |
3,563,955
+45,284
| +1% | +$5.17M | 0.63% | 27 |
|
|
2021
Q2 | $396M | Sell |
3,518,671
-14,652
| -0.4% | -$1.65M | 0.65% | 26 |
|
|
2021
Q1 | $382M | Buy |
3,533,323
+25,436
| +0.7% | +$2.72M | 0.67% | 25 |
|
|
2020
Q4 | $376M | Buy |
3,507,887
+30,400
| +0.9% | +$2.92M | 0.72% | 17 |
|
|
2020
Q3 | $305M | Sell |
3,477,487
-321,378
| -8% | -$30.3M | 0.67% | 24 |
|
|
2020
Q2 | $373M | Buy |
3,798,865
+9,170
| +0.2% | +$807K | 0.84% | 15 |
|
|
2020
Q1 | $289M | Buy |
3,789,695
+25,005
| +0.7% | +$2.13M | 0.76% | 21 |
|
|
2019
Q4 | $333M | Buy |
3,764,690
+3,290,719
| +694% | +$273M | 0.68% | 22 |
|
|
2019
Q3 | $35.9M | Sell |
473,971
-29,649
| -6% | -$2.03M | 0.62% | 39 |
|
|
2019
Q2 | $36.6M | Sell |
503,620
-17,902
| -3% | -$1.41M | 0.63% | 38 |
|
|
2019
Q1 | $42M | Sell |
521,522
-5,864
| -1% | -$480K | 0.75% | 30 |
|
|
2018
Q4 | $48.6M | Sell |
527,386
-37,288
| -7% | -$3.28M | 1% | 18 |
|
|
2018
Q3 | $53.4M | Sell |
564,674
-25,203
| -4% | -$2.39M | 0.96% | 17 |
|
|
2018
Q2 | $54.7M | Sell |
589,877
-20,822
| -3% | -$2.03M | 1.04% | 14 |
|
|
2018
Q1 | $57.8M | Sell |
610,699
-9,592
| -2% | -$1.05M | 1.1% | 13 |
|
|
2017
Q4 | $60M | Buy |
620,291
+42,870
| +7% | +$4.04M | 1.12% | 13 |
|
|
2017
Q3 | $51.3M | Sell |
577,421
-4,125
| -0.7% | -$314K | 1% | 13 |
|
|
2017
Q2 | $42.2M | Buy |
581,546
+4,873
| +0.8% | +$328K | 0.84% | 18 |
|
|
2017
Q1 | $37.6M | Sell |
576,673
-21,638
| -4% | -$1.36M | 0.76% | 22 |
|
|
2016
Q4 | $37.5M | Sell |
598,311
-119
| -0% | -$7.26K | 0.77% | 23 |
|
|
2016
Q3 | $37.7M | Buy |
598,430
+8,972
| +2% | +$581K | 0.78% | 24 |
|
|
2016
Q2 | $36.5M | Buy |
589,458
+63,293
| +12% | +$3.86M | 0.77% | 23 |
|
|
2016
Q1 | $30.1M | Buy |
526,165
+46,520
| +10% | +$2.59M | 0.78% | 23 |
|
|
2015
Q4 | $28.4M | Buy |
479,645
+48,907
| +11% | +$2.82M | 0.74% | 24 |
|
|
2015
Q3 | $23.4M | Buy |
430,738
+4,689
| +1% | +$305K | 0.61% | 36 |
|
|
2015
Q2 | $28.6M | Buy |
426,049
+71,146
| +20% | +$4.64M | 0.77% | 24 |
|
|
2015
Q1 | $20.8M | Sell |
354,903
-9,861
| -3% | -$596K | 0.6% | 38 |
|
|
2014
Q4 | $23.9M | Sell |
364,764
-7,434
| -2% | -$469K | 0.7% | 30 |
|
|
2014
Q3 | $21.5M | Sell |
372,198
-18,976
| -5% | -$1.05M | 0.65% | 37 |
|
|
2014
Q2 | $22.1M | Sell |
391,174
-7,765
| -2% | -$407K | 0.66% | 35 |
|
|
2014
Q1 | $20.5M | Sell |
398,939
-2,355
| -0.6% | -$119K | 0.65% | 37 |
|
|
2013
Q4 | $21.2M | Sell |
401,294
-1,300
| -0.3% | -$63.9K | 0.68% | 34 |
|
|
2013
Q3 | $18M | Buy |
402,594
+4,391
| +1% | +$195K | 0.64% | 39 |
|
|
2013
Q2 | $16.5M | Buy |
+398,203
| New | +$17.4M | 0.61% | 41 |
|
Other funds holding ABBV
VCM
VPM
Truist Financial's ABBV Position: Q1 2026 in Review
Truist Financial increased its AbbVie (ABBV) stake by 0.09% in Q1 2026, buying an estimated $493K and bringing the position to 2,404,493 shares worth $523M. The position accounts for 0.71% of the portfolio, ranked #26.
Truist Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $553M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Truist Financial held 2,404,493 shares of AbbVie worth $523M as of Q1 2026.
- Truist Financial bought 2,223 AbbVie shares in Q1 2026, an estimated $493K.
- AbbVie made up 0.71% of Truist Financial's portfolio in Q1 2026, its #26 holding.
- Truist Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Truist Financial's AbbVie position peaked at $553M in Q1 2022.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.